FDA Calendar for Anavex Life Sciences Corp (AVXL.OB)

| Register (free)
Anavex Life Sciences Corp. (Anavex) is a development-stage company. The Company is focused on developing and marketing drug targets for the treatment of cancer and diseases of the central nervous system (CNS). The Company was formerly engaged in the business of providing online photofinishing services through its Website. As of September 30, 2008, the Company had several compounds at various pre-clinical stages. The Company’s portfolio involves new sigma receptor compounds (ligands) in pre-clinical stage that target diseases of the CNS and cancer. Anavex SIGMACEPTOR-N program involves the discovery and development of original drug candidates, targeting neurological and neurodegenerative diseases, such as Alzheimer’s disease, epilepsy and depression. Anavex SIGMACEPTOR-C program involves the discovery and development of original drug candidates targeting cancer.

Around The Net


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
ANAVEX 2-73 Cancer UnknownPreclinical


Events

No future events listed at this time, please check back later.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

AVXL.OB

$1.72
-0.01 -0.58%
2/3/2012 3:57:00 PM

Sponsors

Other Links